Tag: ankylosing spondylitis
Phase II proof-of-concept clinical study of Namilumab for ankylosing spondylitis initiated
Izana Bioscience, a biopharmaceutical company focused on translational medicine, has announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing...
Positive top-line results for second phase 3 study of Taltz in...
The results of the COAST-W trial demonstrate that Taltz (ixekizumab; Eli Lilly and Company) is a safe and effective treatment for Ankylosing Spondylitis (AS),...
CIMZIA effective in treating axial spondyloarthritis patients
CIMZIA (certolizumab pegol) is the first therapy to demonstrate positive results in a 52-week, placebo controlled non-radiographic axial spondyloarthritis study. The positive topline results...
Combination of NSAIDs and TNF-inhibitors shows benefit for ankylosing spondylitis
A combination of nonsteroidal anti-inflammatory drugs and TNF-inhibitors may help slow down spine damage in ankylosing spondylitis, according to new research findings presented at...
Statins may lower mortality risk in ankylosing spondylitis patients
Patients with ankylosing spondylitis or psoriatic arthritis who take statins may have as much as a 33% lower mortality risk, according to new research...